Interestingly, despite the well-assessed cytoprotective role in normal kidney, the chronic activation of the NRF2 pathway in ccRCC supports tumor progression and metastasis formation [26,29]. This evidence concerns the gene NFE2L2 and nonpapillary renal cell carcinoma.